Lets Talk Eczema Logo
  • Take control
  • Get support
  • Know more about AD (Eczema)
  • Tools to support your new conversation
    • Step 1 > Understand the impact of your AD
    • Step 2 > Set your goals
    • Step 3 > Plan for your next appointment
Lets Talk Eczema Logo
AbbVie Logo

SA-IMM-220022 March 2023
Preparation: June 2023

In the event of any drug adverse event, please contact SFDA to report on 19999

Permission number: (45-SFDA-36)

Take control

Get support

Know more about AD (Eczema)

Tools to support  your new conversation

Step 1 > Know more about AD (Eczema)

Step 2 > Set Your goals

Step 3 > Plan for your next appointment

Terms of use

Privacy Policy

You are now leaving
this website

Continue to site >
< Cancel
  • www-d.lets-talk-eczema.com
  • www-q.lets-talk-eczema.com
  • preview.lets-talk-eczema.com
  • www.lets-talk-eczema.com
  • lets-talk-eczema.com